β-alanyl-L-arginine

Metabolite details

Identifier

DLRGFJGVZXSSTP-LURJTMIESA-N

InChI Key

DLRGFJGVZXSSTP-LURJTMIESA-N

IUPAC name

β-alanyl-L-arginine

Preferred name

β-alanyl-L-arginine

INN name

—

Synonym

(2S)-5-{[amino(imino)methyl]amino}-2-[(3-aminopropanoyl)amino]pentanoic acid

ChEBI

CHEBI:28712

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Unknown Metabolite Annotation in Mouse Aging using Ion Mobility Collision Cross-Section Atlas (AllCCS)
• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole
• Metabolic Responses of a Model Green Microalga Euglena gracilis to Different Environmental Stresses
• Changes and correlations of intestinal flora and liver metabolite profiles in mice with gallstones
• Anti-anemia drug FG4592 retards the AKI to CKD transition by improving vascular regeneration and anti-oxidative capability (day 21)
• Multi-omic Profiling of Multi-Biosamples Reveals the Role of Amino Acid and Nucleotide Metabolism in Endometrial Cancer
• Comparative Analysis of Host Metabolic Alterations in Murine Malaria Models with Uncomplicated or Severe Malaria

Observed in differential profiles

• 36_week_vs_104_week
• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• WT_vs_WT_Aco
• Control_vs_Paramycin
• Control_vs_Lithogenic_Diet
• Sham_vs_UIR
• Control_vs_Endometrial_Cancer
• Uninfected_BALB/c_vs_Plasmodium_yoelii_17XL_BALB/c